Date - 24 March 2021
Venue - Senate Alcove, Parliament House Canberra
Lunch time presentation
Minister for Health Greg Hunt. Also presenting will be.
“How pathology technology drove Australia’s world leading COVID-19 response.”
This Seminar will highlight the important role technology played in our fight against the COVID-19 pandemic. We will look at the innovations that our sector developed to help in the fight. We will project forward to the important and ongoing role pathology technology innovations can play in the healthcare of Australians and the importance of a robust innovation and commercialisation culture. If we are successful, we can maximise our supply chain resilience and establish Australia as a hub for developing, manufacturing and exporting world class pathology technology.
Opening by The Minister for Health Greg Hunt
Professor Mary-Louise McClaws, Epidemiologist UNSW and Adviser to the WHO – Will contrast the local experience with COVID-19 to that in other parts of the world, linking this to pandemic management, testing and the technology. What learnings we can take away to do even better next time?
Adjunct Professor John Skerritt, Deputy Secretary Health Product Registration - Will speak on the role played by the regulator in ensuring swift but safe registration of diagnostic devices were available to detect the SARS-CoV-2 virus. Working with the technology suppliers to make sure Australians had access to high quality testing kits.
Dr John Melki, CEO and Director Genetic Signatures – Will discuss innovation and product development of Australian testing technology with examples from COVID-19 and observations about how we can better prepare for future insults.
Dean Whiting, CEO of Pathology Technology Australia will Chair the seminar.
We will be broadcasting 2 of the Canberra sessions via Zoom, The first broadcast (9:30 to 10:30am) will cover the Innovations Panel Discussion featuring-
We will cover the importance of a strong pathology technology sector to Australia’s supply chain resilience and how some of these technologies contributed to Australia’s response to the COVID-19 pandemic. How else can this sector ensure greater sovereign capability and supply chain resilience? And how can we retain the focus of multinational innovation companies to participate in the Australian healthcare market?
The second broadcast (12 noon to 1:30pm) will focus on the role of our members in keeping Australians safe during the pandemic and will be opened by the Minister for Health Greg Hunt. Also presenting will be.